MyxoTech GmbH
PrivateLast Round
Grant
Jan 1, 2024
Company Overview
MyxoTech GmbH is a biotechnology company that provides a library of natural products derived from myxobacteria to pharmaceutical companies for drug discovery in indications outside of infectious disease.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MyxoTech GmbH Comparables
Compare MyxoTech GmbH with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kapoose Creek Bio | 79% | |
| Generare | 78% | |
| Biosortia Microbiomics | 78% | |
MyxoTech GmbH Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 1, 2024 |
MyxoTech GmbH Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Helmholtz Association | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2024
Received grant funding from Helmholtz Association.
MyxoTech GmbH Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about MyxoTech GmbH's valuation, stock price, and market status.